# The Efface of Ketamine vs. Magnesium Sulphate in the Management of Pain After Laparoscopic Cholecystectomy

> **NCT07248358** · PHASE1 · COMPLETED · sponsor: **Liaquat National Hospital & Medical College** · enrollment: 78 (actual)

## Conditions studied

- Laparoscopic Cholecystectomy Surgery
- Postoperative Pain Management

## Interventions

- **DRUG:** IV ketamine 0.5 mg/kg
- **DRUG:** IV 2mg of Magnesium Sulphate

## Key facts

- **NCT ID:** NCT07248358
- **Lead sponsor:** Liaquat National Hospital & Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-10-20
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248358, "The Efface of Ketamine vs. Magnesium Sulphate in the Management of Pain After Laparoscopic Cholecystectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07248358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*